Ani Pharmaceuticals

ANIPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.757 B

$78.25 -5.30%

Close of 7 Aug 2026

Revenue

$883.4M

#1594 by revenue

Earnings

$78.0M

#1405 by earnings

Shares outstanding

22,491,281

Latest filing cover page

P/E ratio

22.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#126Sarepta TherapeuticsSRPT$1.77B
#127Ascentage Pharma Group InternationalAAPG$1.77B
#128Ani PharmaceuticalsANIP$1.76B
#129SepternaSEPN$1.75B
#130ZymeworksZYME$1.72B

Where these numbers come from

Share counts and financials for Ani Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.